Please assess the completion status of the following clinical trial:

Trial Title: Azithromycin in the Prevention of Lung Injury in Premature Newborn

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* preterm infants of less than 37 weeks of gestational age who have undergone mechanical ventilation within the first 72 hours of life~Exclusion Criteria:~* Major congenital malformations or chromosomal syndromes Mothers carrying the HIV virus.

- Gender: ALL
- Minimum Age: 1 Minute
- Maximum Age: 72 Hours
- Healthy Volunteers: t

Study Arms:
- azithromycin group (Type: EXPERIMENTAL): A control group composed of 40 newborns receiving azithromycin
- placebo group (Type: PLACEBO_COMPARATOR): comparative group composed of 40 newborns who would receive saline 0.9%

Based on this trial design, predict the completion outcome and termination type (if applicable).